Alla Arzumanyan net worth
Quick answer
Alla Arzumanyan's estimated net worth is $15.0M (range $10.5M – $22.5M) as of 2026. Alla Arzumanyan is Founder at SFA Therapeutics. SFA Therapeutics valuation.
Alla Arzumanyan is Founder at SFA Therapeutics (YC S21). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Region: United States of America
- Industries: Healthcare, Therapeutics
- Team size: 4
- Website: https://sfatherapeutics.com/
Who is Alla Arzumanyan?
Alla Arzumanyan is a participant in the Y Combinator Summer 2021 batch with SFA Therapeutics, a company focused on innovative therapeutics.
About SFA Therapeutics
SFA Therapeutics is creating therapeutically-tailored oral drugs that regulate the immune system; with a focus on autoimmune diseases and cancers that originate from chronic inflammation. There are over 300 million patients who suffer from autoimmune diseases. Our treatment is designed to block the root cause of many of these chronic inflammatory diseases, with safe oral drugs. We have strong clinical data from a...
FAQ: Alla Arzumanyan net worth and SFA Therapeutics valuation
What is Alla Arzumanyan's net worth?
Alla Arzumanyan's estimated net worth is $15.0M (range $10.5M – $22.5M) as of 2026. Alla Arzumanyan is Founder at SFA Therapeutics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is SFA Therapeutics valuation?
SFA Therapeutics's estimated valuation on Entrepreneurial Check is $45.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Alla Arzumanyan's role?
Alla Arzumanyan is Founder at SFA Therapeutics, a Y Combinator-backed startup (batch S21).